Session 1: Immunotherapy for advanced cancer: Checkpoint inhibitors

  • Location:
    AIDA
  • Chairs:
     S. Bettuzzi, Parma (IT)
     E. Oosterwijk, Nijmegen (NL)
Introduction
 E. Nossner, Munich (DE)
ESOU lecture: Clinical trials using checkpoint inhibitors in urological carcinomas
 G.N. Thalmann, Berne (CH)
Potential biomarkers for immune therapy
 N. McGranahan, London (GB)